RxDoctor Payments Data

Christy Sno

Medical · Springfield, ORNPI 1811067069

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $6,379 of the $8,417 with a category attached, or 75.8%. It is spread thinly across 26 manufacturers, the largest accounting for just 19.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,165, 6.6 times the $480 reported in 2021. Among medical clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$8,417in general payments, 2019–2025

Across 300 payments — averaging $28.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$2K
  • Regeneron$2K
  • AbbVie$1K
  • Lilly USA, LLC$596
  • Regeneron Healthcare Solutions, Inc.$549
  • UCB, Inc.$501
  • plus $2K from 20 others

What the payments were for

  • Consulting fees$1,37016%
  • Food & beverage$6,37976%
  • Education$6688%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,417 in reported general payments places this provider in the 95th percentile of 364 medical providers in Oregon.

See all medical providers in Oregon

Medicare billing

Part B allowed, 2024
$125,195
Medicare patients
433
Services billed
2,962

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab35$432,693
Dupixent PenDupilumab48$191,926
Cosentyx Sensoready (2 Pens)Secukinumab20$181,933
Cosentyx Unoready PenSecukinumab17$150,010
Clobetasol Propionate116$5,779
Fluorouracil43$3,491
Triamcinolone Acetonide169$2,447
Doxycycline Hyclate66$2,008
Minocycline Hcl25$1,035
Fluocinonide24$1,013
Betamethasone Dipropionate19$936
ValacyclovirValacyclovir Hcl22$824
Spironolactone27$660
Metronidazole11$489
Fluconazole19$422

Paid to pharmacies, not to this prescriber.

Other medical in Springfield

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →